Replies to post #12332 on Cel Sci Corporation (CVM)

[Foxwoods Man]

Excellent article from last year.

Note: CVM price on the day it was released was $10.82 (IHub quote adjusted for split)

[Trustbaby]

Do you think their guess about patients not dying fast enough was the reason for the proposed trial change?

[lux1]

Thank you Montana, I agree with the article, and it's less clear why they want to stop the trial now with hundreds of patients not tested for 3 year yet..
It could be because Multikine works better in the first year vs SOC or because of cash problem. No clue.
Again, I find Geert very repetitive and shallow with the story of SOC of hundred year old(X-ray or I WW chemo).